drugset / Trial / NCT07339631

Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults

NCT07339631 ↗

Phase 1 Recruiting 40 enrolled Xijing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to assess the clinical efficacy and safety of sodium aescinate in treating low back pain (LBP) in adult participants.

Timeline

Start
2026-03-01
Primary completion
2029-09-01
Completion
2029-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium aescinate Unknown 60 mg Oral

Indications

No indication recorded.